Ivermectin changed course of Covid-19 pandemic in SA, claims doctor

Covid-19 recovery rates rose dramatically from 88% to 92% after drug introduced

Covid-19 recovery rates rose dramatically from 88% to 92% over the past week and some doctors believe the widespread use of Ivermectin played a role.

This was according to Dr Naseeba Kathrada, an activist for the use of the drug against the pandemic.

Kathrada spoke out about the controversial drug after it became known that the recovery rate increased dramatically from 88% to 92% over the past week.

Dr. Angelique Coetzee, chairperson of the South African Medical Association.

At the same time, patients on ventilators dropped from 70% to 30% of hospitalised patients.

The South African Health Products Regulatory Authority (Sahpra) approved the use of the drug, which is not registered for humans in the country, under very strict conditions.

This after doctors started advocating for the use of the drug, which is earmarked for animals but sometimes used for cases of river blindness and other parasitical illnesses in humans.

South Africans in their thousands started using the drug leading to a shortage of Ivermectin at several farmer stores around the country and resulted in farmers battling to vaccinate their animals.

“This widespread illegal use of the drug certainly contributed to the much improved statistics,” Kathrada told Izak du Plessis.

Watch the video:

Kathrada’s claim comes amid concerns that South Africans will have to wait even longer to get vaccinated.

The AstraZeneca vaccination, which arrived in the country last week, was recently found to be ineffective against the South African strain of the coronavirus.

On Sunday, the government suspended its roll-out of the AstraZeneca vaccine after preliminary data found it provided only “minimal protection” against the new variant. Dr. Angelique Coetzee, chairperson of the South African Medical Association, told Izak du Plessis that it is back to square one now.

People’s Media News



The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

About Steve Cook 2280 Articles
Director, UK Reloaded

Be the first to comment

Leave a Reply

Your email address will not be published.